Visualize HL7 Example and Test Instances (vi7eti), pronounced /viːˈsɛtiː/
Disclaimer: FOR TEST AND EXAMPLE PURPOSES ONLY! These web pages are not intended to be used as a source of information on on healthcare or medicines. The web pages are not kept up to date and are for demonstration purposes only. For up-to-date information on a medicine, please consult www.ema.europa.eu/medicines or the package leaflet of your medicine. For up-to-date information on other healthcare topics, please consult the relevant reliable sources or an healthcare expert, such as a physician etc.
BACK TO LIST

European Patient Summary

Patient
Name: Blanc, Danielle
DOB: 27-JAN-1996 (Age: 29)
Gender: female
ID: 5911-421838-7 (ECI)
Author
Dr. Ping, Hel
Patient summary Document
European Patient Summary
Report Date: 29-OCT-2024

Problem list

No known problems or disabilities

Medication list

No known medications

Immunizations list

Vaccine Date
Influenza virus antigen only vaccine product 29-Oct-2024
Hepatitis B virus antigen only vaccine product 13-Sep-2016
Clostridium tetani toxoid antigen adsorbed only vaccine product 08-Sep-2015
Neisseria meningitidis antigen-containing vaccine product 08-Sep-2015

Procedure History list

Procedure Date Reason
Epidural anesthesia 05-Nov-2024 Normal pregnancy
Parturition 05-Nov-2024 Normal pregnancy
Assessment of health and social care needs 07-May-2019 -
Assessment of anxiety 07-May-2019 -
Patient evaluation and management 13-Jun-2018 -
Complete blood count 13-Jun-2018 -
Blood culture 13-Jun-2018 -
Urine specimen collection 13-Jun-2018 -
Patient discharge 13-Jun-2018 -
Taking patient vital signs 13-Jun-2018 -
History taking 13-Jun-2018 -
Discussion about signs and symptoms 13-Jun-2018 -
Antibiotic therapy 13-Jun-2018 -
Triage: emergency center 13-Jun-2018 -
Urinalysis with reflex to microscopy and culture 13-Jun-2018 -
Comprehensive metabolic panel 13-Jun-2018 -

Allergies and Intolerances

Allergy/Intolerance Onset Date Status Type Reaction
Mold 1995-07-29 active environment Nose running<br> </br>Wheezing
Latex 1995-07-29 active environment
House dust mite 1995-07-29 active environment
Animal dander 1995-07-29 active environment Rhinoconjunctivitis (disorder)<br> </br>Cough (finding)
Allergy to substance 1995-07-29 active environment
Tree nut 1995-07-29 active food Anaphylaxis (disorder)<br> </br>Wheal (finding)

Care Plan

Active Planned Care / Goals Start Date Reason
Routine antenatal care 22-Apr-2025 -
Asthma self management 19-Apr-1997 Childhood asthma
  • Patient will demonstrate correct inhaler technique and adhere to asthma action plan to minimize asthma symptoms and prevent exacerbations.
Self-care interventions 13-Jul-1995 -

Vital Signs

Vital Signs 2024-10-29 2023-10-24
Body Height 168.5 cm 168.5 cm
Pain severity - 0-10 verbal numeric rating [Score] - Reported 3 {score} 0 {score}
Body Weight 76.7 kg 75.2 kg
Body mass index (BMI) [Ratio] 27 kg/m2 26.5 kg/m2
Diastolic Blood Pressure 76 mm[Hg] 74 mm[Hg]
Systolic Blood Pressure 136 mm[Hg] 137 mm[Hg]
Heart rate 92 /min 75 /min
Respiratory rate 14 /min 15 /min

Pregnancy History

$
[#] Births total 1

Relevant diagnostic tests/laboratory data

Recent Lab Observations 29-OCT-2024 Reference Range Unit
Cholesterol [Mass/volume] in Serum or Plasma 124.7 L 130 - 200 mg/dL
Triglyceride [Mass/volume] in Serum or Plasma 109.9 35 - 150 mg/dL
Cholesterol in LDL [Mass/volume] in Serum or Plasma by Direct assay 47.5 0 - 130 mg/dL
Cholesterol in HDL [Mass/volume] in Serum or Plasma 55.2 40 - 100 mg/dL